Norio Nonomura

Author PubWeight™ 145.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2013 5.82
2 Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy. Int J Urol 2012 2.13
3 Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation. J Urol 2009 1.80
4 Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res 2002 1.59
5 Sesquiterpene lactone parthenolide ameliorates bladder inflammation and bladder overactivity in cyclophosphamide induced rat cystitis model by inhibiting nuclear factor-kappaB phosphorylation. J Urol 2009 1.59
6 Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance. Liver Transpl 2012 1.49
7 Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years. Int J Urol 2009 1.48
8 Carbamylated erythropoietin ameliorates cyclosporine nephropathy without stimulating erythropoiesis. Cell Transplant 2012 1.47
9 A phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma: insights into the treatment, efficacy and safety. Jpn J Clin Oncol 2009 1.47
10 Juxtaglomerular cell tumor that was preoperatively diagnosed using selective renal venous sampling. Intern Med 2013 1.44
11 A single nucleotide polymorphism within the novel sex-linked testis-specific retrotransposed PGAM4 gene influences human male fertility. PLoS One 2012 1.44
12 The growth-inhibitory effects of dexamethasone on renal cell carcinoma in vivo and in vitro. Cancer Invest 2008 1.44
13 Survey of overactive bladder symptoms influencing bother before and after treatment with tamsulosin hydrochloride in Japanese patients with benign prostatic hyperplasia. Urology 2011 1.43
14 Adipose tissue-derived stem cells suppress acute cellular rejection by TSG-6 and CD44 interaction in rat kidney transplantation. Transplantation 2014 1.43
15 Microvessel area of immature vessels is a prognostic factor in renal cell carcinoma. Int J Urol 2013 1.42
16 White blood cell count is positively associated with benign prostatic hyperplasia. Int J Urol 2013 1.41
17 High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder. Urology 2005 1.40
18 Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy. Int J Urol 2015 1.40
19 Bone marrow-derived cells contribute to regeneration of injured prostate epithelium and stroma. Prostate 2015 1.38
20 Standardized diagram improves diagnostic accuracy and variability in the identification of testicular cells prepared for testicular sperm extraction and intracytoplasmic sperm injection. Urology 2013 1.38
21 Overall survival and updated results from a phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma. Jpn J Clin Oncol 2010 1.28
22 Renal cell carcinoma in dialysis patients: a single center experience. Int J Urol 2006 1.26
23 Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions. Int J Radiat Oncol Biol Phys 2010 1.22
24 Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis. Int J Oncol 2007 1.21
25 Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB. Int J Cancer 2007 1.21
26 Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin Cancer Res 2004 1.21
27 Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors. Mod Pathol 2008 1.15
28 Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 2005 1.14
29 [A case report of prostatic stromal tumor of uncertain malignant potential (STUMP)]. Hinyokika Kiyo 2008 1.11
30 Risk factors for malignancy in Japanese renal transplant recipients. Cancer 2007 1.10
31 Inflammation and prostate carcinogenesis. Int J Urol 2012 1.07
32 Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: comparison of laparoscopic and open surgery. Eur Urol 2005 1.06
33 Clinical outcome and prognostic factors of sorafenib in Japanese patients with advanced renal cell carcinoma in general clinical practice. Jpn J Clin Oncol 2011 1.06
34 Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res 2003 1.05
35 High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer. Radiother Oncol 2006 1.04
36 Utility of the Japanese GFR estimation equation for evaluating potential donor kidney function. Clin Exp Nephrol 2009 1.03
37 Excision repair cross-complementing group 1 may predict the efficacy of chemoradiation therapy for muscle-invasive bladder cancer. Clin Cancer Res 2010 1.02
38 KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors. Biochem Biophys Res Commun 2005 0.98
39 Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis. Int J Cancer 2002 0.97
40 Utility of immunohistochemical detection of prostate-specific Ets for the diagnosis of benign and malignant prostatic epithelial lesions. Int J Urol 2002 0.96
41 Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors. Cancer 2002 0.96
42 Urgency is an independent factor for sleep disturbance in men with obstructive sleep apnea. Urology 2010 0.95
43 Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 2008 0.95
44 The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study. World J Urol 2011 0.94
45 Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1/2 and c-Myc. Mol Cancer Res 2013 0.94
46 Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection. Transplantation 2012 0.94
47 SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer. Biochem Biophys Res Commun 2009 0.93
48 Isolation of germ cells from leukemia and lymphoma cells in a human in vitro model: potential clinical application for restoring human fertility after anticancer therapy. Cancer Res 2006 0.92
49 [Myxofibrosarcoma of the spermatic cord: a case report]. Nihon Hinyokika Gakkai Zasshi 2008 0.92
50 Androgen decline in patients with nonobstructive azoospemia after microdissection testicular sperm extraction. Urology 2008 0.92
51 EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. PLoS One 2013 0.91
52 Superagonist CD28 antibody preferentially expanded Foxp3-expressing nTreg cells and prevented graft-versus-host diseases. Cell Transplant 2009 0.91
53 Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy. Int J Clin Oncol 2012 0.91
54 Hydrogen-rich University of Wisconsin solution attenuates renal cold ischemia-reperfusion injury. Transplantation 2012 0.90
55 Epigallocatechin-3-gallate protects kidneys from ischemia reperfusion injury by HO-1 upregulation and inhibition of macrophage infiltration. Transpl Int 2011 0.90
56 Clinical comparison of successful and failed microdissection testicular sperm extraction in patients with nonmosaic Klinefelter syndrome. Urology 2007 0.88
57 Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancer. Prostate 2014 0.88
58 Importance of continuing therapy and maintaining one-month relative dose intensity in sunitinib therapy for metastatic renal cell carcinoma. Med Oncol 2012 0.88
59 Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations. BJU Int 2009 0.88
60 Rare case of aggressive angiomyxoma presenting as a retrovesical tumor. Int J Urol 2006 0.88
61 Orthosiphon grandiflorum has a protective effect in a calcium oxalate stone forming rat model. Urol Res 2010 0.87
62 Carbamylated erythropoietin improves angiogenesis and protects the kidneys from ischemia-reperfusion injury. Cell Transplant 2008 0.87
63 Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan. Int J Clin Oncol 2012 0.87
64 One-month relative dose intensity of not less than 50% predicts favourable progression-free survival in sorafenib therapy for advanced renal cell carcinoma in Japanese patients. Eur J Cancer 2011 0.86
65 Postatrophic hyperplasia of the prostate in Japan: histologic and immunohistochemical features and p53 gene mutation analysis. Prostate 2002 0.86
66 The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer. J Radiat Res 2013 0.86
67 Abdominal Tuberculosis: peritoneal involvement shown by F-18 FDG PET. Clin Nucl Med 2007 0.86
68 Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy. Int J Clin Oncol 2014 0.85
69 Prostate cancer mediates osteoclastogenesis through two different pathways. Cancer Lett 2005 0.85
70 Involvement of heregulin/HER3 in the primary culture of human urothelial cancer. J Urol 2013 0.85
71 [A case report of retroperitoneal fibrosis associated with IgG4-related sclerosing disease]. Hinyokika Kiyo 2010 0.85
72 Effect of sex hormones on crystal formation in a stone-forming rat model. Urology 2010 0.85
73 Sex differences in visual attention to sexually explicit videos: a preliminary study. J Sex Med 2008 0.85
74 [Two cases of bladder cancer with hereditary nonpolyposis colorectal cancer]. Hinyokika Kiyo 2011 0.84
75 Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cells. Int J Androl 2003 0.84
76 High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients. BMC Cancer 2014 0.83
77 Vitamin D deficiency predicts decline in kidney allograft function: a prospective cohort study. J Clin Endocrinol Metab 2013 0.82
78 In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors. Prostate 2004 0.82
79 Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor. Int J Urol 2007 0.82
80 Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma. Hum Pathol 2013 0.82
81 Why does atorvastatin inhibit renal crystal retention? Urol Res 2011 0.82
82 Prognostic significance of thymidylate synthase expression in patients with prostate cancer undergoing radical prostatectomy. Urology 2007 0.82
83 Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells. Int J Cancer 2011 0.82
84 Pulmonary metastasectomy in patients with renal cell carcinoma: a single-institution experience. Int J Clin Oncol 2011 0.82
85 Post-chemotherapy nerve-sparing retroperitoneal lymph node dissection for advanced germ cell tumor. Int J Urol 2009 0.82
86 A case of renal cell carcinoma with multiple lung metastases refractory to interferon-alpha showing complete remission by interleukin-2 monotherapy. Int J Urol 2006 0.81
87 Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation. Bone 2012 0.81
88 A nonerythropoietic derivative of erythropoietin inhibits tubulointerstitial fibrosis in remnant kidney. Clin Exp Nephrol 2012 0.81
89 Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: preliminary findings. J Sex Med 2011 0.81
90 Solitary skin metastasis adjacent to ureterocutaneostomy 4 years after radical cystectomy for bladder cancer. Jpn J Clin Oncol 2012 0.81
91 Androgen-regulated transcriptional control of sialyltransferases in prostate cancer cells. PLoS One 2012 0.81
92 Solifenacin may improve sleep quality in patients with overactive bladder and sleep disturbance. Urology 2011 0.80
93 Vascular endothelial growth factor receptor 1 expression in pelvic lymph nodes predicts the risk of cancer progression after radical prostatectomy. Cancer Sci 2009 0.80
94 Preoperative induction with sorafenib pathologically downstaged advanced renal cell carcinoma: a case report. Int J Urol 2010 0.80
95 Clinical trial of treatment with saikokaryukotsuboreito for eugonadal patients with late-inset hypogonadism-related symptoms. Aging Male 2008 0.80
96 The blocking of CXCR3 and CCR5 suppresses the infiltration of T lymphocytes in rat renal ischemia reperfusion. Nephrol Dial Transplant 2012 0.80
97 Lower urinary tract symptoms after hormone replacement therapy in Japanese patients with late-onset hypogonadism: a preliminary report. Int J Urol 2009 0.80
98 Weekly, low-dose docetaxel combined with estramustine for Japanese castration-resistant prostate cancer: its efficacy and safety profile compared with tri-weekly standard-dose treatment. Int J Clin Oncol 2013 0.80
99 Successful superselective arterial embolization for post-traumatic high-flow priapism. Int J Urol 2007 0.80
100 Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus. Clin Transplant 2005 0.80
101 Lower urinary tract symptoms and erectile dysfunction associated with depression among Japanese patients with late-onset hypogonadism symptoms. Aging Male 2010 0.80
102 Early efficacy of silodosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Int J Urol 2008 0.80
103 [A case of leiomyosarcoma of prostate: multimodality therapy suppressed disease progression for long term]. Hinyokika Kiyo 2010 0.80
104 Co-expression of ERCC1 and Snail is a prognostic but not predictive factor of cisplatin-based neoadjuvant chemotherapy for bladder cancer. Oncol Lett 2012 0.80
105 Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis. Nephrol Dial Transplant 2007 0.79
106 [(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive therapy efficacy in rat experimental autoimmune encephalomyelitis model. J Neuroimmune Pharmacol 2011 0.79
107 Mechanism underlying the low prevalence of pediatric calcium oxalate urolithiasis. J Urol 2009 0.79
108 Effect of human leukemia cells in testicular tissues grafted into immunodeficient mice. Int J Urol 2008 0.79
109 Sexual life of Japanese patients with erectile dysfunction taking phosphodiesterase type 5 inhibitors: an Internet survey using the Psychological and Interpersonal Relationship Scales-Short Form questionnaire. Int J Urol 2014 0.79
110 [A case of bronchogenic cyst treated as retroperitoneal tumor]. Hinyokika Kiyo 2013 0.79
111 Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers. Cancer 2003 0.79
112 Orally active vitamin d for potential chemoprevention of posttransplant malignancy. Cancer Prev Res (Phila) 2012 0.79
113 Olfactory mucosal transplantation after spinal cord injury improves voiding efficiency by suppressing detrusor-sphincter dyssynergia in rats. J Urol 2010 0.79
114 Retracted Testis-specific protein on Y chromosome (TSPY) represses the activity of the androgen receptor in androgen-dependent testicular germ-cell tumors. Proc Natl Acad Sci U S A 2010 0.79
115 [Inflammatory myofibroblastic tumor of the bladder: a case report]. Hinyokika Kiyo 2008 0.79
116 High-dose chemotherapeutics of intravesical chemotherapy rapidly induce mitochondrial dysfunction in bladder cancer-derived spheroids. Cancer Sci 2014 0.79
117 Low serum free testosterone level is associated with carotid intima-media thickness in middle-aged Japanese men. Endocr J 2012 0.79
118 Non-invasive magnetic resonance imaging in rats for prediction of the fate of grafted kidneys from cardiac death donors. PLoS One 2013 0.78
119 Nitric oxide synthesis leads to vascular endothelial growth factor synthesis via the NO/cyclic guanosine 3',5'-monophosphate (cGMP) pathway in human corpus cavernosal smooth muscle cells. J Sex Med 2008 0.78
120 Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys. Urology 2011 0.78
121 Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study. World J Urol 2014 0.78
122 A case of polymyositis associated with adrenal carcinoma. Int J Urol 2007 0.78
123 Adverse event profile and dose modification of everolimus for advanced renal cell carcinoma in real-world Japanese clinical practice. Jpn J Clin Oncol 2013 0.78
124 Analysis of Fas gene mutations on laser capture microdissected specimens from renal cell carcinoma. Jpn J Cancer Res 2002 0.78
125 Diversity in protein profiles of individual calcium oxalate kidney stones. PLoS One 2013 0.78
126 Relation between erectile dysfunction and urinary incontinence after nerve-sparing and non-nerve-sparing radical prostatectomy. Urol Int 2004 0.78
127 The effects of androgen deprivation therapy with weight management on serum aP2 and adiponectin levels in prostate cancer patients. Aging Male 2015 0.78
128 Significant antitumor effect of intratumoral ethanol injection on renal cell carcinoma. Eur Urol 2003 0.78
129 Occurrence of free deaminoneuraminic acid (KDN)-containing complex-type N-glycans in human prostate cancers. Glycobiology 2012 0.78
130 Improvement of nocturia and sleep disturbance by silodosin in male patients with lower urinary tract symptoms. Int J Urol 2014 0.78
131 [Adrenal ganglioneuroma: a case report]. Hinyokika Kiyo 2005 0.77
132 Relationship between substances in seminal plasma and Acrobeads Test results. Fertil Steril 2008 0.77
133 Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia. Urology 2013 0.77
134 Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link? Int J Urol 2009 0.77
135 Hepatocyte growth factor has protective effects on crystal-cell interaction and crystal deposits. Urology 2006 0.77
136 Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer. BJU Int 2008 0.77
137 Significance of electrostimulation in detecting neurovascular bundle during radical prostatectomy. Int J Urol 2006 0.77
138 [Periureteral inflammatory pseudotumor: a case report]. Hinyokika Kiyo 2003 0.77
139 A clear correlation between WT1-specific Th response and clinical response in WT1 CTL epitope vaccination. Anticancer Res 2010 0.77
140 Elucidation of the mechanism of crystal-cell interaction using fibronectin-overexpressing Madin-Darby canine kidney cells. Urol Int 2007 0.77
141 Clinical experience with laparoscopic radical nephrectomy for renal cell carcinoma. Urol Int 2008 0.77
142 Favorable outcome in elderly Asian patients with metastatic renal cell carcinoma treated with everolimus: the Osaka Urologic Oncology Group. Asian Pac J Cancer Prev 2014 0.76
143 Urological surgery in patients aged 80 years and older: a 30-year retrospective clinical study. Int J Urol 2008 0.76
144 Recent topics related to testosterone deficiency syndrome in Japan. Asian J Androl 2011 0.76
145 5alphaDH-DOC (5alpha-dihydro-deoxycorticosterone) activates androgen receptor in castration-resistant prostate cancer. Cancer Sci 2010 0.76
146 Is low testosterone concentration a risk factor for metabolic syndrome in healthy middle-aged men? Urology 2013 0.76
147 Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism. Aging Male 2010 0.76
148 Retrospective analysis of an oral combination of dexamethasone, uracil plus tegafur and cyclophosphamide for hormone-refractory prostate cancer. Jpn J Clin Oncol 2010 0.76
149 Three successful cases of bilateral testicular tumors where the unilateral testis was preserved by three courses of BEP chemotherapy. Int J Urol 2007 0.75
150 Frequent Fas gene mutations in testicular germ cell tumors. Am J Pathol 2002 0.75
151 Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase. Anticancer Drugs 2016 0.75
152 Analysis of late toxicity associated with external beam radiation therapy for prostate cancer with uniform setting of classical 4-field 70 Gy in 35 fractions: a survey study by the Osaka Urological Tumor Radiotherapy Study Group. J Radiat Res 2012 0.75
153 Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution. Anticancer Drugs 2016 0.75
154 Brain responses during the first desire to void: a positron emission tomography study. Int J Urol 2008 0.75
155 Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism? Int J Urol 2008 0.75
156 [A case of primary malignant lymphoma of the prostate]. Hinyokika Kiyo 2011 0.75
157 Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men. Tumour Biol 2014 0.75
158 [Castleman disease in the pelvic cavity]. Hinyokika Kiyo 2005 0.75
159 [A case of metachronous testicular tumor developing seven years after complete remission of retroperitoneal extragonadal germ cell tumor]. Hinyokika Kiyo 2009 0.75
160 New year's greetings. Int J Urol 2016 0.75
161 [Prostate cancer--the role of adrenal steroids]. Nihon Rinsho 2011 0.75
162 [Leiomyosarcoma of the kidney with tumor thrombus to the inferior vena cava]. Hinyokika Kiyo 2010 0.75
163 [A case of bladder cancer producing granulocyte colony-stimulating factor and interleukin-6 causing respiratory failure treated with neoadjuvant systemic chemotherapy along with sivelestat]. Hinyokika Kiyo 2013 0.75
164 [Solitary metastasis of renal cell carcinoma to the contralateral ureter: a case report]. Hinyokika Kiyo 2009 0.75
165 [Testicular cancer metastatic to multiple organs including the stomach, kidneys, and skin: a case report]. Hinyokika Kiyo 2006 0.75
166 Laparoscopic adrenalectomy for primary hyperaldosteronism: clinical experience with 60 cases. J Endourol 2006 0.75
167 [Case report of prostatic stromal tumor of uncertain malignant potential (STUMP)]. Hinyokika Kiyo 2010 0.75
168 [Hormonal chemotherapy for hormone-refractory prostate cancer]. Hinyokika Kiyo 2002 0.75
169 Prostate-specific antigen measured 3 months after radical prostatectomy as a new predictor of biochemical recurrence. Int J Clin Oncol 2014 0.75
170 [A case of clear cell adenocarcinoma of the female urethra]. Hinyokika Kiyo 2003 0.75
171 [The growing teratoma syndrome report of a case]. Nihon Hinyokika Gakkai Zasshi 2006 0.75
172 [A case of retroperitoneal leiomyosarcoma with abdominal wall recurrence 7 years after the first operation]. Hinyokika Kiyo 2012 0.75
173 [A case of clear cell adenocarcinoma arising from a female urethral diverticulum]. Hinyokika Kiyo 2011 0.75
174 [Treatment strategy for stage I testicular germ cell tumor]. Hinyokika Kiyo 2012 0.75
175 [A case report of pyogenic spondylodiscitis mimicking spinal metastasis of urothelial carcinoma]. Hinyokika Kiyo 2010 0.75
176 [Renal neuroendocrine tumor (carcinoid) : a case report]. Hinyokika Kiyo 2013 0.75
177 [Leydig cell tumor of the testis presenting male infertility: a case report]. Hinyokika Kiyo 2003 0.75
178 [Living unrelated renal transplantation in an eldery couple: a case report]. Hinyokika Kiyo 2006 0.75
179 [A case of malignant lymphoma in the pelvis suspected to be a neurogenic tumor]. Hinyokika Kiyo 2013 0.75
180 Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 2012 0.75
181 Retraction for Akimoto et al., Testis-specific protein on Y chromosome (TSPY) represses the activity of the androgen receptor in androgen-dependent testicular germ-cell tumors. Proc Natl Acad Sci U S A 2014 0.75
182 [Imaging analysis of central nerve system for sexual arousal and sexual interest]. Rinsho Shinkeigaku 2012 0.75
183 Finger taps and constipation are closely related to symptoms of overactive bladder in male patients with Parkinson's disease. Int J Urol 2013 0.75
184 Morphologic and mitochondrial characterization of human spermatogenic cells dispersed in wet preparation for testicular sperm extraction: establishment of a microscopic diagram of developing human spermatogenic cells. Fertil Steril 2011 0.75
185 [Synchronous bilateral chromophobe cell renal carcinoma: a case report]. Hinyokika Kiyo 2009 0.75
186 Relationship between Pulmonary Adverse Events and Everolimus Exposure in Japanese and Non-Japanese Patients: A Meta-Analysis of Oncology Trials. Oncology 2017 0.75
187 [A case of androgen insensitivity syndrome (AIS) treated by Laparoendoscopic single site surgery (LESS)]. Hinyokika Kiyo 2011 0.75
188 [Therapy for hormone-refractory prostate cancer]. Nihon Rinsho 2002 0.75
189 Type-I interferon receptor expression: its circadian rhythm and downregulation after interferon-alpha administration in peripheral blood cells from renal cancer patients. Int J Urol 2009 0.75
190 A single daily dose enhances the adherence to immunosuppressive treatment in kidney transplant recipients: a cross-sectional study. Clin Exp Nephrol 2012 0.75
191 New year's greetings. Int J Urol 2017 0.75
192 Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients. Clin Exp Nephrol 2011 0.75
193 Water avoidance stress induces frequency through cyclooxygenase-2 expression: a bladder rat model. Int J Urol 2011 0.75
194 [Successful renal contraction therapy in polycystic kidney patient with renal transcatheter arterial embolization prior to ABO incompatible kidney transplantation]. Nihon Hinyokika Gakkai Zasshi 2010 0.75
195 [Adenocarcinoma of the sigmoid segment 38 years after sigmoidcystoplasty : a case report]. Hinyokika Kiyo 2011 0.75
196 [Cardiorespiratory arrest due to acute pulmonary thromboembolism during chemotherapy for female urothelial carcinoma of urethra: a case report]. Hinyokika Kiyo 2013 0.75
197 [A case of paratesticular rhabdomyosarcoma]. Hinyokika Kiyo 2008 0.75
198 Tumor multiplicity is an independent prognostic factor of non-muscle-invasive high-grade (T1G3) bladder cancer. Jpn J Clin Oncol 2009 0.75
199 The impact on graft survival of interstitial inflammation in borderline change of allograft kidneys. Nephrology (Carlton) 2014 0.75
200 Prolonged Mouse Cardiac Graft Cold Storage via Attenuating Ischemia-Reperfusion Injury Using a New Antioxidant-Based Preservation Solution. Transplantation 2016 0.75
201 [Renal pelvic cancer with tumor thrombus in the vena cava inferior: a case report]. Hinyokika Kiyo 2004 0.75
202 Urothelial carcinoma in an ectopic ureter. Urology 2009 0.75
203 Changes in extent and zonal distribution of prostatic adenocarcinoma in patients preoperatively treated with neoadjuvant endocrine therapy: analysis on whole-mounted prostatectomy specimens. Int J Urol 2002 0.75
204 [Molecular-targeted therapy for hormone-refractory prostate cancer]. Hinyokika Kiyo 2006 0.75
205 Gene mutations: analysis in proliferative prostatic diseases using laser capture microdissection. Methods Enzymol 2002 0.75
206 Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association. Jpn J Clin Oncol 2016 0.75
207 [Subclinical Cushing's syndrome with primary aldosteronism with the developing symptom of complications : a case report]. Hinyokika Kiyo 2013 0.75
208 [Bone metastasis from prostate cancer]. Clin Calcium 2014 0.75